MicroRNA miR-425 is a negative regulator of atrial natriuretic peptide
- 期刊名称BMC Pharmacology and Toxicology
- 作者Arora, Pankaj; Wu, Connie; Bloch, Donald B; Davis-Dusenbury, Brandi N; Spagnolli, Ester; Hata, Akiko; Vandenwijngaert, Sara; Swinnen, Melissa; Janssens, Stefan; Buys, Emmanuel S; Bloch, Kenneth D; Newton-Cheh, Christopher; Wang, Thomas J
- 卷第14卷
- 印刷ISSN2050-6511
- 文件大小68.29KB
- 发表时间2013-08
- DOI10.1186/2050-6511-14-S1-O10
NO-H2S interactions involve cGMPPapapetropoulos, Andreas · BMC Pharmacology and Toxicology · 2013
Natriuretic peptides and fat metabolismCollins, Sheila · BMC Pharmacology and Toxicology · 2013
BMCPharmacology and Toxicologyreviewer acknowledgement 2014Morrey, Christopher · BMC Pharmacology and Toxicology · 2015
BMC Pharmacology and Toxicologyreviewer acknowledgement 2015Morrey, Christopher · BMC Pharmacology and Toxicology · 2016
cGMP and cardiac hypertrophyRuwan K Perera,Hariharan Subramanian,Alexander Froese… · BMC Pharmacology and Toxicology · 2015
Reviewer acknowledgement 2013Helena C Flemyng · BMC Pharmacology and Toxicology · 2014
Chronic natriuretic peptide protein therapeuticsChen, Horng H; Cataliotti, Alessandro; Burnett, John C · BMC Pharmacology and Toxicology · 2013
sGC redox regulation and asthmaDennis J Stuehr,Arnab Ghosh,Cynthia J Koziol-White… · BMC Pharmacology and Toxicology · 2015